Figure 4:
KDIGO risk categories among FLOW participants. Data are n (%) for each category. To facilitate recruitment to the FLOW trial and increase generalisability of the outcomes by reflecting typical clinical practice, eligibility in terms of laboratory results could be based on historical values. Adapted from the KDIGO Diabetes Work Group, 2020 [3].